Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, 110036, China.
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, 6431 Fannin, Suite 3.222, Houston, TX, 77030, USA.
Sci Rep. 2021 Jan 28;11(1):2593. doi: 10.1038/s41598-021-82219-y.
Levels of intestinal toll-like receptor 4 (TLR4) impact inflammation in the neonatal gastrointestinal tract. While surfactant protein A (SP-A) is known to regulate TLR4 in the lung, it also reduces intestinal damage, TLR4 and inflammation in an experimental model of necrotizing enterocolitis (NEC) in neonatal rats. We hypothesized that SP-A-deficient (SP-A) mice have increased ileal TLR4 and inflammatory cytokine levels compared to wild type mice, impacting intestinal physiology. We found that ileal TLR4 and proinflammatory cytokine levels were significantly higher in infant SP-A mice compared to wild type mice. Gavage of neonatal SP-A mice with purified SP-A reduced ileal TLR4 protein levels. SP-A reduced expression of TLR4 and proinflammatory cytokines in normal human intestinal epithelial cells (FHs74int), suggesting a direct effect. However, incubation of gastrointestinal cell lines with proteasome inhibitors did not abrogate the effect of SP-A on TLR4 protein levels, suggesting that proteasomal degradation is not involved. In a mouse model of experimental NEC, SP-A mice were more susceptible to intestinal stress resembling NEC, while gavage with SP-A significantly decreased ileal damage, TLR4 and proinflammatory cytokine mRNA levels. Our data suggests that SP-A has an extrapulmonary role in the intestinal health of neonatal mice by modulating TLR4 and proinflammatory cytokines mRNA expression in intestinal epithelium.
肠型 toll 样受体 4(TLR4)水平影响新生儿胃肠道炎症。虽然表面活性蛋白 A(SP-A)已知可调节肺部的 TLR4,但它还可减少实验性坏死性小肠结肠炎(NEC)新生大鼠模型中的肠道损伤、TLR4 和炎症。我们假设 SP-A 缺乏(SP-A)小鼠与野生型小鼠相比,回肠 TLR4 和促炎细胞因子水平升高,从而影响肠道生理学。我们发现,与野生型小鼠相比,婴儿 SP-A 小鼠的回肠 TLR4 和促炎细胞因子水平显着升高。用纯化的 SP-A 灌胃新生 SP-A 小鼠可降低回肠 TLR4 蛋白水平。SP-A 降低了正常人类肠上皮细胞(FHs74int)中 TLR4 和促炎细胞因子的表达,表明存在直接作用。然而,用蛋白酶体抑制剂孵育胃肠道细胞系并没有消除 SP-A 对 TLR4 蛋白水平的影响,这表明蛋白酶体降解不参与其中。在实验性 NEC 的小鼠模型中,SP-A 小鼠对类似于 NEC 的肠道应激更敏感,而 SP-A 灌胃可显着降低回肠损伤、TLR4 和促炎细胞因子 mRNA 水平。我们的数据表明,SP-A 通过调节肠道上皮细胞中 TLR4 和促炎细胞因子 mRNA 的表达,在新生小鼠的肠道健康中发挥了肺外作用。